BlackRock’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Sell
10,068,614
-107,873
-1% -$131K ﹤0.01% 3373
2025
Q4
$10M Sell
10,176,487
-504,240
-5% -$605K ﹤0.01% 3475
2025
Q3
$13.5M Sell
10,680,727
-129,754
-1% -$140K ﹤0.01% 3294
2025
Q2
$12.1M Buy
10,810,481
+128,702
+1% +$150K ﹤0.01% 3313
2025
Q1
$8.44M Sell
10,681,779
-259,803
-2% -$318K ﹤0.01% 3401
2024
Q4
$18.1M Buy
10,941,582
+468,332
+4% +$1.18M ﹤0.01% 3111
2024
Q3
$36.7M Buy
10,473,250
+357,144
+4% +$1.39M ﹤0.01% 2663
2024
Q2
$33.2M Buy
10,116,106
+1,016,155
+11% +$4.45M ﹤0.01% 2681
2024
Q1
$66.8M Sell
9,099,951
-2,112,865
-19% -$13.1M ﹤0.01% 2284
2023
Q4
$41.9M Sell
11,212,816
-1,271,674
-10% -$3M ﹤0.01% 2593
2023
Q3
$26.5M Buy
12,484,490
+505,932
+4% +$1.68M ﹤0.01% 2780
2023
Q2
$57M Buy
11,978,558
+502,315
+4% +$2.77M ﹤0.01% 2402
2023
Q1
$65.4M Buy
11,476,243
+1,750,019
+18% +$10.6M ﹤0.01% 2276
2022
Q4
$98.1M Buy
9,726,224
+1,808,803
+23% +$34M ﹤0.01% 2011
2022
Q3
$177M Buy
7,917,421
+501,445
+7% +$14.5M 0.01% 1563
2022
Q2
$184M Buy
7,415,976
+310,305
+4% +$8.56M 0.01% 1590
2022
Q1
$275M Buy
7,105,671
+45,119
+0.6% +$1.75M 0.01% 1430
2021
Q4
$413M Buy
7,060,552
+365,006
+5% +$20.7M 0.01% 1178
2021
Q3
$397M Buy
6,695,546
+99,586
+2% +$7.81M 0.01% 1170
2021
Q2
$572M Sell
6,595,960
-567,527
-8% -$45.7M 0.02% 916
2021
Q1
$591M Buy
7,163,487
+491,946
+7% +$47.1M 0.02% 868
2020
Q4
$607M Buy
6,671,541
+104,907
+2% +$6.51M 0.02% 770
2020
Q3
$262M Buy
6,566,634
+466,488
+8% +$16.3M 0.01% 1168
2020
Q2
$209M Buy
6,100,146
+514,786
+9% +$15.3M 0.01% 1330
2020
Q1
$124M Sell
5,585,360
-207,327
-4% -$5.24M 0.01% 1502
2019
Q4
$113M Buy
5,792,687
+534,343
+10% +$8.49M ﹤0.01% 1892
2019
Q3
$81.7M Buy
5,258,344
+80,055
+2% +$1.53M ﹤0.01% 2015
2019
Q2
$105M Sell
5,178,289
-12,985
-0.3% -$234K ﹤0.01% 1876
2019
Q1
$91.2M Buy
5,191,274
+159,491
+3% +$2.52M ﹤0.01% 1920
2018
Q4
$64.6M Buy
5,031,783
+1,562,252
+45% +$21.8M ﹤0.01% 2079
2018
Q3
$56.5M Buy
3,469,531
+183,701
+6% +$2.17M ﹤0.01% 2311
2018
Q2
$37.3M Buy
3,285,830
+382,821
+13% +$4.22M ﹤0.01% 2517
2018
Q1
$28.3M Buy
2,903,009
+1,197,716
+70% +$11.5M ﹤0.01% 2575
2017
Q4
$10.4M Buy
1,705,293
+43,499
+3% +$194K ﹤0.01% 3123
2017
Q3
$6.58M Buy
1,661,794
+3,067
+0.2% +$10.4K ﹤0.01% 3377
2017
Q2
$5.38M Buy
1,658,727
+1,572,438
+1,822% +$6.02M ﹤0.01% 3454
2017
Q1
$392K Buy
+86,289
New +$316K ﹤0.01% 4032

Other funds holding FATE